Summary Stage 2018: Intracranial Gland
Summary Stage 2018
Notes
**Intracranial Gland**
**Malignant histologies (/3):** 8000-8700, 8720-8790, 8900, 9064, 9070-9071, 9080, 9084-9085, 9100, 9120, 9140, 9220, 9362, 9380-9539, 9680, 9699, 9702-9715, 9751-9759
**Benign/Borderline histologies (/0, /1):** All histologies (8000-9993)
C751-C753
C751 Pituitary gland
C752 Craniopharyngeal duct
C753 Pineal Gland
**Note 1:** The following sources were used in the development of this chapter
* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)
* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)
* Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx
* Chapter 72 *Brain and Spinal Cord*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.
**Note 2:** While all histologies with behavior /0 and /1 are captured in this chapter, for behavior /3, see the following chapters for the listed histologies
* 8710-8714, 8800-8898, 8901-8934, 8940-9063, 9065, 9072-9073, 9081-9083, 9086-9091, 9101-9111, 9121-9138, 9141-9213, 9221-9261, 9363-9373, 9540-9582: *Soft Tissue*
* 8935-8936: *GIST*
* 9700-9701: *Mycosis Fungoides*
**Note 3:** Summary Stage is the only applicable staging system for this site/histology/schema.
**Note 4:** Assign code 8 for benign or borderline tumors.
**Note 5:** Codes 3 and 4 are not applicable for this chapter.
| SS2018 |
Description |
| 0 |
In situ, intraepithelial, noninvasive |
| 1 |
Localized only (localized, NOS)
- Confined to gland of origin |
| 2 |
Regional by direct extension only
- Adjacent connective/soft tissue
- Adjacent organ(s)/structure(s) for pituitary and craniopharyngeal duct
+ Cavernous sinus
+ Infundibulum
+ Pons
+ Sphenoid body and sinuses
- Adjacent organ(s)/structure(s) for pineal
+ Infratentorial and central brain |
| 7 |
Distant site(s)/lymph node(s) involved
- Distant site(s) (including further contiguous extension)
- Distant lymph node(s), NOS
- Distant metastasis, NOS
+ Carcinomatosis
+ Distant metastasis WITH or WITHOUT distant lymph node(s) |
| 8 |
Benign or borderline brain |
| 9 |
Unknown if extension or metastasis |
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998
(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.
(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05.** American Joint Committee on Cancer (Chicago, IL)
(4) Laws, E.R., Curran, W.J., et al. **Brain and Spinal Cord**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017
